Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1994-1-6
pubmed:abstractText
We investigated the effects of anti-murine CD44 monoclonal antibodies on the activation of antigen-specific T cell hybridomas. Anti-murine CD44 antibodies by themselves did not induce the production of IL-2 by antigen-specific T cell hybridomas. However, anti-murine CD44 monoclonal antibodies were able to either inhibit or enhance the production of IL-2, depending on the other monoclonal antibodies used as comitogenic stimuli. When a T cell hybridoma was activated by antigen and antigen-presenting cells or anti-CD3 antibodies, addition of anti-CD44 antibodies inhibited IL-2 production. In contrast, monoclonal anti-CD44 antibodies acted in synergy with anti-human CD2 antibodies in stimulating a murine T cell hybridoma stably transfected with the human CD2 gene to produce IL-2. Therefore, cross-linking of surface CD44 is able to deliver either a positive or a negative signal in murine antigen-specific T cell hybridomas. One of the ligands for CD44 is hyaluronic acid. Hyaluronic acid in vitro significantly increased the activation of murine T cell hybridomas. Hyaluronic acid itself was mitogenic for T cell hybridomas. Therefore, in addition to being an adhesion molecule, CD44 functions as a signal-transducing molecule on murine T cell hybridomas.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0008-8749
pubmed:author
pubmed:issnType
Print
pubmed:volume
152
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
186-99
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:7694807-Animals, pubmed-meshheading:7694807-Antibodies, Monoclonal, pubmed-meshheading:7694807-Antigen-Presenting Cells, pubmed-meshheading:7694807-Antigens, CD2, pubmed-meshheading:7694807-Antigens, CD3, pubmed-meshheading:7694807-Antigens, CD44, pubmed-meshheading:7694807-Antigens, Differentiation, T-Lymphocyte, pubmed-meshheading:7694807-Drug Synergism, pubmed-meshheading:7694807-Humans, pubmed-meshheading:7694807-Hyaluronic Acid, pubmed-meshheading:7694807-Hybridomas, pubmed-meshheading:7694807-Interleukin-2, pubmed-meshheading:7694807-Male, pubmed-meshheading:7694807-Mice, pubmed-meshheading:7694807-Mice, Inbred BALB C, pubmed-meshheading:7694807-Mitogens, pubmed-meshheading:7694807-Receptors, Antigen, T-Cell, pubmed-meshheading:7694807-Receptors, Immunologic, pubmed-meshheading:7694807-Receptors, Lymphocyte Homing, pubmed-meshheading:7694807-Signal Transduction, pubmed-meshheading:7694807-Transfection
pubmed:year
1993
pubmed:articleTitle
Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
pubmed:affiliation
Institute of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't